Overview

Efficacy and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in de Novo Kidney Transplant Recipients

Status:
Completed
Trial end date:
2005-10-01
Target enrollment:
Participant gender:
Summary
This trial is designed to assess the efficacy, tolerability, and safety of EC-MPS in combination with cyclosporine microemulsion (CsA-ME) with or without steroids in kidney transplant recipients.
Phase:
Phase 4
Details
Lead Sponsor:
Novartis
Treatments:
Mycophenolate mofetil
Mycophenolic Acid